FDA Approves Generic HIV-Prevention Shot for Global Access
The U.S. Food and Drug Administration has approved a generic version of a twice-yearly HIV-prevention shot, lenacapavir, aiming to make it affordable and accessible in 120 low- and middle-income countries. The generic drug is not currently available in the U.S.…
Detroit, MI, November 2, 2026 — The U.S. Food and Drug Administration (FDA) has announced the approval of a generic version of lenacapavir, a medication used for the prevention of HIV. This development aims to increase the affordability and accessibility of the treatment, particularly in lower-income regions worldwide.
The generic drug is intended for administration as a twice-yearly shot, a regimen designed for long-acting HIV prevention. The FDA’s approval specifically targets making this preventative measure available in 120 low- and middle-income countries. The intention behind this approval is to broaden the reach of effective HIV prevention tools to populations that may have faced significant cost barriers with the brand-name version.
However, the generic version of lenacapavir is not currently available within the United States. This unavailability is attributed to existing patent protections that are in place for the brand-name version of the drug. The specifics regarding the duration of these patent protections were not provided in the summary.
The approval marks a significant step towards global health equity by potentially reducing the economic burden associated with HIV prevention. The focus on low- and middle-income countries underscores an effort to combat the disproportionate impact of HIV in these regions. Further details regarding the manufacturing of the generic drug and its rollout schedule in the designated countries were not immediately available. The contractor responsible for manufacturing the generic version was not named. The timeline for when the generic version might become available in the U.S. market, should patent protections expire or be circumvented, remains undetermined.
Story summarized from the original created by AP via Scripps News Group on www.wxyz.com, see more information here.
